Papers In Press, published online ahead of print February 9, 2004
J. Biol. Chem, 10.1074/jbc.M310737200
Submitted on September 29, 2003
Revised on February 6, 2004
Accepted on February 9, 2004
Identification of a ZU5 and death domain containing inhibitor of NF-kB
Jun Zhang, Liang-Guo Xu, Ke-Jun Han, and Hong-Bing Shu
Department of Immunology, National Jewish Medical and Research Center, Denver, Colorado 80206
Corresponding Author: shuh{at}njc.org
The transcription factor NF-kB plays important roles in inflammation and cell survival. NF-kB is composed of homodimeric and heterodimeric complexes of Rel/NF-kB family members, including p65 (RelA), c-Rel (Rel), RelB, NF-kB1/p50 and NF-kB2/p52. Here we report the identification and characterization of a novel ZU5 and death domain containing protein designated as ZUD. In reporter gene assays, overexpression of ZUD inhibited NF-kB-dependent transcription induced by TNF, IL1 and their downstream signaling proteins. Gel shift assays indicated that overexpression of ZUD inhibited binding of NF-kB to its target sequence. ZUD is a cytoplasmic protein and coimmunoprecipitation assays indicated that ZUD interacted with the NF-kB subunit p105 and transactivator p65. Consistent with its role in inhibition of NF-kB-dependent transcription, ZUD sensitized cells to apoptosis induced by TNF and TRAIL. Our findings suggest that ZUD is an inhibitor of NF-kB activation and this protein may provide an alternative regulatory mechanism of NF-kB-mediated transcription.